Pharmacists News

• Tandem Insulin Pump System Integrates With Libre Sensor Tandem Diabetes Care's t:slim X2 insulin pump becomes the first to integrate with Abbott's FreeStyle Libre 2 Plus Sensor for US users.
  Medscape Medical News, January 08, 2024
• African Psychedelic Remarkably Improved TBI-Related Symptoms Treatment with ibogaine (psychoactive agent) led to "remarkable" improvement in severe functional disability and psychiatric symptoms related to TBI, early findings suggested.
  Medscape Medical News, January 08, 2024
• Which Therapies Reduce Daytime Symptoms of Insomnia? Zolpidem and behavior therapy each reduce daytime symptoms of insomnia such as fatigue, functional impairments, and depressive symptoms, data suggested.
  Medscape Medical News, January 07, 2024
  2
• Alert FDA Gives Nod to Berdazimer Gel for Molluscum Contagiosum The topical treatment is expected to be commercially available in the second half of 2024.
  Medscape Medical News, January 05, 2024
  1
• Eli Lilly Offers Obesity Drug Directly to Consumers Eli Lilly launched its direct-to-patient portal on Thursday, providing its obesity medicine (as well as diabetes and migraine drugs) direct to the consumer.
  WebMD Health News, January 05, 2024
  27
• FDA Evaluating 3 Side Effects Reported for Weight Loss Drugs A new report listed potential links between GLP-1 agonists and alopecia, aspiration during surgery, and suicidal ideation.
  WebMD Health News, January 05, 2024
  24
• Expert Highlights Biologics in the Pipeline for Eczema Dr David Rosmarin reviewed several biologics in clinical trials that target interleukin-4 and other receptors.
  MDedge News, January 05, 2024
• Wegovy, Ozempic Not Linked to Increase in Suicidal Thoughts, US Study Finds A large U.S. study found no evidence that taking Novo Nordisk's Ozempic or Wegovy is tied to an increase in suicidal thoughts, researchers reported on Friday.
  Reuters Health Information, January 05, 2024
• Long-term Clopidogrel Has Advantages After Coronary Stenting Clopidogrel after PCI was noninferior to aspirin for net adverse clinical events but superior in reducing secondary endpoints of stroke and MI, in 5-year STOPDAPT-2 results.
  Medscape Medical News, January 05, 2024
  2
• Merck Seeks GLP-1 Drugs With Benefits Beyond Weight Loss - CEO Merck & Co is seeking GLP-1 treatments with benefits beyond weight loss, CEO Robert Davis said on Thursday at a conference.
  Reuters Health Information, January 04, 2024
• US Dermatologic Drug Approvals Rose Between 2012 and 2022 Of the 52 new drugs approved in the past decade, 21% were categorized as first in class, but more innovations are needed for skin diseases with unmet therapeutic needs, the authors said.
  Medscape Medical News, January 04, 2024
• Higher-Dose Atypical Antipsychotics Risky in Young Adults Higher doses of a second-generation antipsychotic are associated with an increased risk of dying in young adults aged 18-24 years, results of a large retrospective cohort study showed.
  Medscape Medical News, January 04, 2024
• Wegovy Maker Novo Nordisk Enters Research Tie-ups With US Biotech Firms Blockbuster weight-loss drug maker Novo Nordisk announced on Thursday research collaborations with two U.S. biotech firms, part of its efforts to stay ahead in big pharma's...
  Reuters Health Information, January 04, 2024
• Experimental Topical Drug Shows Promise for AD, Psoriasis In the phase 2 study, researchers at 34 sites in four countries randomized 104 patients with mild to moderate AD or psoriasis to receive the topical PDE4 inhibitor or a vehicle once daily for 6 weeks.
  MDedge News, January 04, 2024
  2
• Pediatric Obesity Specialists Struggle to Get GLP-1s The medications can reduce or eliminate weight-related complications in children but are in short supply, and insurers are denying coverage, said pediatricians.
  Medscape Medical News, January 03, 2024
  1
• Digital Assistant Helps Ease an Overactive Bladder A digital tool may represent a more accessible and less expensive alternative to pelvic floor therapy.
  Medscape Medical News, January 03, 2024
• 5-Year Safety Data From Upadacitinib Trials Reported Upadacitinib trials in atopic dermatitis have included diverse patient groups with varying risk factors, according to Dr Christopher Bunick.
  MDedge News, January 03, 2024
  1
• Extreme Heat and Hypoglycemia Risk in Older Insulin Users In a large study on older adults with diabetes on insulin in the United States and Taiwan, exposure to higher heat and humidity was associated with an increased risk for serious hypoglycemic events.
  Medscape Medical News, January 02, 2024
  2
• Weight-loss Drugs: Who, and What, Are They Good For? Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to...
  Reuters Health Information, January 02, 2024
• Window for Post-Stroke Antiplatelet Therapy Can Be Extended Dual antiplatelet therapy initiated up to 72 hours post-stroke cuts the risk for recurrent stroke but comes with increased bleeding risk, new data from the INSPIRES trial showed.
  Medscape Medical News, January 02, 2024
  5
• US Sets Policy to Seize Patents If Drug Price Deemed Too High The Biden Administration has announced it is setting new policy that will allow it to seize patents for medicines developed with government funding if it believes their prices are too high.
  Reuters Health Information, December 07, 2023
• CVS Plans to Simplify Drug Pricing Process CVS Health on Tuesday forecast 2024 revenue above market estimates and said it would simplify the structure through which its pharmacies get reimbursed for drugs.
  Reuters Health Information, December 05, 2023
• US Regulators Inspect Dr Reddy's, Other Indian Pharma Majors The US Food and Drug Administration is inspecting Dr Reddy's research and development centre in the southern Indian city of Hyderabad, the pharma company said on Tuesday.
  Reuters Health Information, December 05, 2023
• MSWS 2023 What's New in Acne Treatment? Advances in acne care include the use of light-based devices.
  Medscape Medical News, December 04, 2023
• How the New Outbreak in China Is Hitting Clinics Elsewhere A rise in respiratory illnesses in China, clusters of pneumonia in children, and resistance to common antibiotics have specialists on alert looking for changes locally.
  Medscape Medical News, December 04, 2023
  46
• Reducing Albumin Improves Kidney and Heart Function The tablet drug finerenone significantly reduces kidney risk in people with type 2 diabetes and also protects heart health, researchers found.
  Medscape Medical News, December 04, 2023
  5
• Statin Use Remains Low for At-Risk Patients Expanded prescribing guidelines have not boosted statin use among patients who are at risk for atherosclerotic cardiovascular disease.
  Medscape Medical News, December 04, 2023
  4
• No Benefit of Levothyroxine in Heart Donors New data challenge the common practice of levothyroxine administration in potential heart donors after brain death to preserve heart function and make more hearts available for transplantation.
  Medscape Medical News, December 04, 2023
  1
• EMA Committee Recommends Label Update for Some Decongestants The European Medicines Agency's safety committee on Friday recommended changes to product information for all medicines that contain the ingredient pseudoephedrine to address safety concerns related to neurological and heart-related side effects.
  Reuters Health Information, December 01, 2023
• MSWS 2023 New Tools Available to Help Diagnose Skin Cancer Emerging technologies aim to improve skin cancer diagnosis without biopsies.
  Medscape Medical News, December 03, 2023
  1
• MSWS 2023 Misdiagnoses Among Challenges in Managing Cutaneous Lymphoma Although predictive tools to identify those at risk of disease progression are in their infancy, the development of such tools is crucial for improving patient outcomes.
  Medscape Medical News, December 02, 2023
• COVID Vaccines Lower Risk of Serious Illness in Kids Two doses of an mRNA COVID-19 vaccine reduced hospitalizations and emergency department visits by 40%.
  Medscape Medical News, December 01, 2023
  38
• FDA Probes Quality Issues With China-Made Plastic Syringes The U.S. Food and Drug Administration said on Thursday it is looking into reports of leaks, breakages and other quality problems with plastic syringes manufactured in China.
  Reuters Health Information, November 30, 2023
• EADV 2023 Novel Subcutaneous Biologics Show Promise in AD Patients with moderate to severe atopic dermatitis could soon have more therapeutic options, with monoclonal antibodies targeting novel immune pathways that reduce disease severity, suggest two trials.
  Medscape Medical News, December 01, 2023
• What Is the Dark Side of GLP-1 Receptor Agonists? Doctors who prescribe this class of medication should be aware of the rare side effects with which it is associated, said an obesity expert.
  Medscape Medical News, December 01, 2023
  34
• Patients Exposed to HIV, Hepatitis at Salem Hospital At least 450 patients at Mass General Brigham, Salem Hospital, near Boston are at risk of HIV and hepatitis infection, according to a lawsuit claiming negligent intravenous medication administration.
  Medscape Medical News, December 01, 2023
  32
• SABCS 2023 SABCS 2023 Highlights Breast Cancer De-Escalation From humble beginnings in 1977, 10,000 people are expected to attend this year's breast cancer meeting in San Antonio.
  Medscape Medical News, December 01, 2023
• Meta-Analysis: Suicide Risk Not Increased With Isotretinoin In fact, those treated with the drug for severe acne may have a lower risk for suicide attempts 2-4 years after treatment, according to the study authors.
  MDedge News, December 01, 2023
• Long-Acting PrEP in Europe's Fight Against HIV Europe's advances in HIV prevention strategies, including PrEP and long-acting retrovirals, bring hope amidst persistent access challenges and disparities.
  Medscape Medical News, December 01, 2023
  7
• ASCO Details How to Manage Ongoing Cancer Drug Shortage The guidance also recommends counseling to help patients and providers who are struggling with 'psychological or moral distress' from ongoing shortages.
  Medscape Medical News, November 30, 2023